Exact Sciences Corporation reported Revenue improvement of 23.12% year on year in the fourth quarter 2025, to $ 878.38 millions, this is lower than Exact Sciences Corporation's recent average Revenue rise of 67.94%.
Looking into fourth quarter 2025 results within Medical Laboratories industry 5 other companies have achieved higher Revenue growth. While Exact Sciences Corporation' s Revenue rise of 23.12% ranks overall at the positon no. 525 in the fourth quarter 2025.
Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025
Exact Sciences's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
253.46 %
15.33 %
-100 %
(Dec 31 2016)
EXAS's IV. Quarter Q/Q Revenue Comment
Exact Sciences Corporation achieved in the IV. Quarter 2025 below company average Revenue growth of 3.35% quarter on quarter, to $ 878.38 millions.
Although the IV. Quarter 2025 Revenue Q/Q growth was lower than the regular , this has been yet encouraging story, as the IV. Quarter surge, eclipses the -0.95% growth in the IV. Quarter a year ago
Within Medical Laboratories industry 2 other companies have achieved higher Revenue quarter on quarter growth. While Exact Sciences's Revenue growth quarter on quarter, overall rank is 314.
Exact Sciences Corporation achieved in the IV. Quarter 2025 below company average Revenue growth of 3.35% quarter on quarter, to $ 878.38 millions.
IV. Quarter 2025 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -0.95% in the IV. Quarter a year ago.
Within Medical Laboratories industry 2 other companies have achieved higher Revenue quarter on quarter growth. While Exact Sciences's Revenue growth quarter on quarter, overall rank is 314.
Exact Sciences's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Dec 31 2025)
12 Months Ending (Sep 30 2025)
12 Months Ending (Jun 30 2025)
12 Months Ending (Mar 31 2025)
12 Months Ending (Dec 31 2024)
Cumulative Revenue 12 Months Ending
$ 3,245.31
$ 3,080.35
$ 2,950.66
$ 2,851.27
$ 2,788.46
Y / Y Revenue Growth (TTM)
16.38 %
13.17 %
12.1 %
11.9 %
11.22 %
Year on Year Revenue Growth Overall
Ranking
# 275
# 356
# 726
# 686
# 136
Seqeuential Revenue Change (TTM)
5.36 %
4.4 %
3.49 %
2.25 %
2.44 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 525
# 864
# 1724
# 1934
# 541
Cumulative Revenue growth Comment
Although Exact Sciences's Annual Revenue growth year on year were below company's average 67.94% , Revenue announced in the Dec 31 2025 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 16.38% year on year, from 13.17% in Sep 30 2025.
Within the Healthcare sector 26 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 275, from total ranking in previous quarter at 356.
Although Exact Sciences's Annual Revenue growth year on year were below company's average 67.94% , Revenue announced in the Dec 31 2025 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 16.38% year on year, from 13.17% in Sep 30 2025.
Within the Healthcare sector 26 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 275, from total ranking in previous quarter at 356.
About Exact Sciences Revenue Growth Rates (EXAS), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
40.01%